Skip to main content

Table 1 Demographics among patients with hemoglobin ≤ 6.5 mmol/L on the 3rd postoperative day

From: Association between intravenous iron therapy and short-term mortality risk in older patients undergoing hip fracture surgery: an observational study

 

No treatment (n=52)

ABT (n=38)

IV Monofer (n=80)

IV Monofer and ABT (n=40)

Total (n=210)

p value

Gender

 Female

28 (53.8)

20 (52.6)

41 (51.2)

18 (45.0)

107 (51.0)

 

 Male

24 (46.2)

18 (47.4)

39 (48.8)

22 (55.0)

103 (49.0)

0.853

Age

82.6 (9.1)

83.2 (7.1)

83.6 (8.9)

84.7 (9.2)

83.5 (8.7)

0.709

BMI (kg/m2)

24.1 (4.2)

24 (5.1)

24.2 (3.9)

23.2 (3.8)

23.9 (4.2)

0.655

Charlson Comorbidity Index

1.9 (2)

2.7 (2.1)

1.9 (2.2)

2.1 (1.7)

2.1 (2.1)

0.219

Polypharmacy (≥5 medications)

34 (65.4)

33 (86.8)

55 (68.8)

34 (85.0)

156 (74.3)

0.023*

Admission source

 Home-independent

38 (73.1)

27 (71.1)

55 (68.8)

29 (72.5)

149 (71.0)

 

 Nursing home

14 (26.9)

11 (28.9)

25 (31.2)

11 (27.5)

61 (29.0)

0.951

Study period

 1

51 (98.1)

37 (97.4)

12 (15.0)

7 (17.5)

107 (51.0)

 

 2

1 (1.9)

1 (2.6)

68 (85.0)

33 (82.5)

103 (49.0)

< 0.001*

Fracture

 Intracapsular

29 (55.8)

14 (36.8)

31 (38.8)

13 (32.5)

87 (41.4)

 

 Extracapsular

23 (44.2)

24 (63.2)

49 (61.2)

27 (67.5)

123 (58.6)

0.098

Operation

 Arthroplasty

19 (36.5)

16 (42.1)

23 (28.8)

7 (17.5)

65 (31.0)

 

 Intramedullary nails

19 (36.5)

21 (55.3)

48 (60.0)

30 (75.0)

118 (56.2)

 

 AO screws

2 (3.8)

0 (0.0)

3 (3.8)

1 (2.5)

6 (2.9)

 

 Dynamic hip screws

7 (13.5)

1 (2.6)

4 (5.0)

1 (2.5)

13 (6.2)

 

 Other

5 (9.6)

0 (0.0)

2 (2.5)

1 (2.5)

8 (3.8)

0.014*

Time to theatre (days)

0.6 (0.5)

0.8 (0.8)

0.8 (0.5)

0.7 (0.6)

0.7 (0.6)

0.425

Preoperative Hgb (mmol/L)

7.7 (0.8)

7.4 (1)

7.9 (0.7)

6.8 (1)

7.5 (0.9)

< 0.001*

 Missing

9

5

19

10

43

 

Perioperative blood loss (mL)

185.7 (108.9)

387.1 (414.1)

205.1 (159.9)

254.7 (196.1)

246.8 (241.1)

0.001*

 Missing

17

7

21

8

53

 

Hgb postoperative day 1 (mmol/L)

6.3 (0.6)

5.4 (0.8)

6.1 (0.6)

5.1 (0.6)

5.8 (0.8)

< 0.001*

 Missing

2

0

0

0

2

 

Hgb postoperative day 3 (mmol/L)

5.8 (0.5)

5.4 (0.7)

5.6 (0.5)

5.2 (0.7)

5.6 (0.6)

< 0.001*

Hgb postoperative between day

14–30 (mmol/L)

6.3 (0.7)

6.4 (0.5)

6.8 (0.6)

6.6 (0.8)

6.6 (0.7)

0.116

 Missing because deceased

5

4

2

4

15

 

 Missing because no hgb control

28

21

48

12

109

 

Length of stay (days)

6.5 (3.9)

7.1 (4)

5.9 (2.1)

6.9 (2.6)

6.5 (3.1)

0.177

Discharged to

 Home-independent

18 (34.6)

14 (36.8)

37 (46.2)

14 (35.0)

83 (39.5)

 

 Nursing home

34 (65.4)

20 (52.6)

43 (53.8)

24 (60.0)

121 (57.6)

 

 Dead in hospital

0 (0.0)

4 (10.5)

0 (0.0)

2 (5.0)

6 (2.9)

0.023*

Readmission/transmission to ICUa

 Readmitted

13 (25.0)

5 (13.2)

14 (17.5)

10 (25.0)

42 (20.0)

 

 Transmitted to ICUa

0 (0.0)

0 (0.0)

1 (1.2)

1 (2.5)

2 (1.0)

0.558

  1. Data are presented as mean ± SD (age, BMI, Charlson Comorbidity Index, perioperative blood loss, time to theatre, hemoglobin levels, length of stay) or number of patients and percentage (all others)
  2. aIntensive Care unit
  3. *p < 0.05